Citations

Showing 10 of 108104 citations.

Developmental delay and failure to thrive associated with a loss‐of‐function variant in WHSC1 (NSD2)
Boczek, Nicole J. , Lahner, Carrie A., Nguyen, Thuy‐mi , Ferber, Matthew J. , Hasadsri, Linda , Thorland, Erik C., Niu, Zhiyv , Gavrilova, Ralitza H. , Niu, Zhiyv

Mayo Clinic

American Journal of Medical Genetics Part A | October 22, 2018 | Volume: 176 | Issue: 12 | Pages: 2798-2802

10.1002/ajmg.a.40498 | PMID 30345613 Get It

Wolf‐Hirschhorn syndrome (WHS) is a microdeletion syndrome characterized by distinctive facial features consisting of “Greek warrior helmet” appearance, prenatal and postnatal growth deficiency, developmental disability, and seizures. This disorder is caused by heterozygous deletions on chromosome 4p16.3 often identified by cytogenetic techniques. Many groups have attempted to identify the critical region within this deletion to establish which genes are responsible for WHS. Herein, clinical whole exome sequencing (WES) was performed on a child with developmental delays, mild facial dysmorphisms, short stature, failure to thrive, and microcephaly, and revealed a de novo frameshift variant, c.1676_1679del (p.Arg559Tfs*38), in WHSC1 (NSD2). While WHSC1 falls within the WHS critical region, individuals with only disruption of this gene have only recently been described in the literature. Loss‐of‐function de novo variations in WHSC1 were identified in large developmental delay, autism, diagnostic, and congenital cardiac cohorts, as well as recent case reports, suggesting that de novo loss‐of‐function WHSC1 variants may be related to disease. These findings, along with our patient suggest that loss‐of‐function variation in WHSC1 may lead to a mild form of Wolf‐Hirschhorn syndrome, and also may suggest that the developmental delays, facial dysmorphisms, and short stature seen in WHS may be due to disruption of WHSC1 gene.
Perioperative Management and In-Hospital Outcomes After Minimally Invasive Repair of Pectus Excavatum: A Multicenter Registry Report From the Society for Pediatric Anesthesia Improvement Network
Muhly, Wallis T. , Beltran, Ralph J. , Bielsky, Alan , Bryskin, Robert B. , Chinn, Christopher D., Choudhry, Dinesh K. , Cucchiaro, Giovanni , Glover, Chris D. , Haile, Dawit T. , Kost‐Byerly, Sabine, Schnepper, Gregory D. , Agarwal, Rita , Bhalla, Tarun , Eisdorfer, Seth, Huang, Henry D. , Thomas, James J. , Tjia, Imelda , Wilder, Robert T., Fernández, Allison M. , Zurakowski, David , Maxwell, Lynne Gerson , Cravero, Joseph P.

Mayo Clinic

Anesthesia & Analgesia | October 22, 2018 | Volume: 128 | Issue: 2 | Pages: 315-327

10.1213/ane.0000000000003829 | PMID 30346358 Get It

BACKGROUND: There are few comparative data on the analgesic options used to manage patients undergoing minimally invasive repair of pectus excavatum (MIRPE). The Society for Pediatric Anesthesia Improvement Network was established to investigate outcomes for procedures where there is significant management variability. For our first study, we established a multicenter observational database to characterize the analgesic strategies used to manage pediatric patients undergoing MIRPE. Outcome data from the participating centers were used to assess the association between analgesic strategy and pain outcomes. METHODS: Fourteen institutions enrolled patients from June 2014 through August 2015. Network members agreed to an observational methodology where each institution managed patients based on their institutional standards and protocols. There was no requirement to standardize care. Patients were categorized based on analgesic strategy: epidural catheter (EC), paravertebral catheter (PVC), wound catheter (WC), no regional (NR) analgesia, and intrathecal morphine techniques. Primary outcomes, pain score and opioid consumption by postoperative day (POD), for each technique were compared while adjusting for confounders using multivariable modeling that included 5 covariates: age, sex, number of bars, Haller index, and use of preoperative pain medication. Pain scores were analyzed using repeated-measures analysis of variance with Bonferroni correction. Opioid consumption was analyzed using a multivariable quantile regression. RESULTS: Data were collected on 348 patients and categorized based on primary analgesic strategy: EC (122), PVC (57), WC (41), NR (120), and intrathecal morphine (8). Compared to EC, daily median pain scores were higher in patients managed with PVC (POD 0), WC (POD 0, 1, 2, 3), and NR (POD 0, 1, 2), respectively ( P < .001–.024 depending on group). Daily opioid requirements were higher in patients managed with PVC (POD 0, 1), WC (POD 0, 1, 2), and NR (POD 0, 1, 2) when compared to patients managed with EC ( P < .001). CONCLUSIONS: Our data indicate variation in pain management strategies for patients undergoing MIRPE within our network. The results indicate that most patients have mild-to-moderate pain postoperatively regardless of analgesic management. Patients managed with EC had lower pain scores and opioid consumption in the early recovery period compared to other treatment strategies.
Superior Capsular Reconstruction With the Addition of an Acromial Acellular Dermal Allograft Spacer
Makovicka, Justin L. , Patel, Karan A. , Tokish, John M. , Patel, Karan

Mayo Clinic

Arthroscopy Techniques | October 22, 2018 | Volume: 7 | Issue: 11 | Pages: No page available

10.1016/j.eats.2018.08.003 | PMID 30533367 Get It

Abstract Superior capsular reconstruction has emerged as a promising technique in the treatment of massive irreparable rotator cuff tears. The technical aspects of the surgery continue to evolve, and scientific studies to evaluate these techniques are emerging. One such area of interest concerns the appropriate thickness of the graft and its role as a spacer. The original description of the graft was an autograft tensor fascia lata, which was folded to achieve a thickness of around 8 mm. It has been demonstrated that an 8‐mm graft is superior biomechanically to a 4‐mm graft, which exceeds the typical human dermal allograft thickness. Herein we describe a technique in which an acellular human dermal allograft was used to perform a superior capsular reconstruction and the remainder of the graft was used to resurface the undersurface of the acromion. This modification of the technique allows for arthroscopic acromial resurfacing, as well as effectively doubling the thickness of the spacer function of the graft. The technique and justification are described in detail, and this has become the senior author's standard approach to the massive irreparable rotator cuff tear in patients with Hamada stages 2 and 3. Technique Video video See video under supplementary data.
P4‐373: PROSTATE CANCER, USE OF ANDROGEN DEPRIVATION THERAPY AND COGNITIVE IMPAIRMENT
Alonso-Quinones, Hector J., Stish, Bradley J. , Hagen, Clinton E., Petersen, Ronald C. , Knopman, David S. , Mielke, Michelle M.

Mayo Clinic

Alzheimer's & Dementia | October 22, 2018 | Volume: 14 | Issue: 7S_Part_30 | Pages: No page available

10.1016/j.jalz.2018.07.197 Get It

P4‐319: CLINICAL FEATURES, CSF BIOMARKERS, MOLECULAR IMAGING, AND PATHOLOGY IN DYSEXECUTIVE ALZHEIMER'S DISEASE
Przybelski, Scott A. , Savica, Rodolfo , Radford, Jonathan Graff, Drubach, Daniel A., Josephs, Keith A. , Lowe, Val J. , Petersen, Ronald C. , Mantyh, William G. , Botha, Hugo , Machulda, Mary M. , Murray, Melissa E. , Polsinelli, Angelina J. , Boeve, Bradley F. , Knopman, David S. , Jack, Clifford R. , Jones, David T.

Mayo Clinic

Alzheimer's & Dementia | October 22, 2018 | Volume: 14 | Issue: 7S_Part_30 | Pages: No page available

10.1016/j.jalz.2018.07.142 Get It

P4‐318: PET MEASUREMENTS OF PHF TAU BURDEN IN COGNITIVELY UNIMPAIRED PERSONS WITH TWO, ONE AND NO COPIES OF THE APOE4 ALLELE
Goradia, Dhruman D., Protas, Hillary , Devadas, Vivek, Tariot, Pierre N. , Lowe, Val J. , Petersen, Ronald C. , Caselli, Richard J. , Reiman, Eric M. , Ghisays, Valentina , Bauer, Robert, Knopman, David S. , Jack, Clifford R. , Chen, Kewei

Mayo Clinic

Alzheimer's & Dementia | October 22, 2018 | Volume: 14 | Issue: 7S_Part_30 | Pages: No page available

10.1016/j.jalz.2018.07.141 Get It

P4‐301: REGION‐LEVEL RELATIONSHIPS BETWEEN TAU, AMYLOID, HYPOMETABOLISM AND ATROPHY IN ATYPICAL ALZHEIMER'S DISEASE
Sintini, Irene , Martin, Peter R. , Graff‐Radford, Jonathan , Spychalla, Anthony J., Drubach, Daniel A., Lowe, Val J. , Josephs, Keith A. , Whitwell, Jennifer L. , Schwarz, Christopher G. , Machulda, Mary M. , Senjem, Matthew L. , Jack, Clifford R.

Mayo Clinic

Alzheimer's & Dementia | October 22, 2018 | Volume: 14 | Issue: 7S_Part_30 | Pages: No page available

10.1016/j.jalz.2018.07.124 Get It

P4‐288: DETAILS OF THE NEW ALZHEIMER'S ASSOCIATION BEST CLINICAL PRACTICE GUIDELINES FOR THE EVALUATION OF NEURODEGENERATIVE COGNITIVE BEHAVIORAL SYNDROMES, ALZHEIMER'S DISEASE AND DEMENTIAS IN THE UNITED STATES
Norman, Mary S., Karlawish, Jason , Sano, Mary , Onyike, Chiadi U. , Lin, Paige E. , Clevenger, Carolyn , Scanland, Susan, Hendrix, James A. , Dickerson, Brad C., Atri, Alireza , Knopman, David S. , Norman, Mary, Lin, Paige, Carrillo, María C.

Mayo Clinic

Alzheimer's & Dementia | October 22, 2018 | Volume: 14 | Issue: 7S_Part_30 | Pages: No page available

10.1016/j.jalz.2018.07.110 Get It

P4‐259: A NOVEL SORL1 TRANSCRIPT THAT IS DOWNREGULATED IN ALZHEIMER'S DISEASE
Monti, Giulia , Comaposada-Baro, Raquel, Wellner, Niels, Reiche, Juliane, Lincoln, Sarah, Allen, Mariet , Ertekin‐Taner, Nilüfer , Melnikova, Margarita, Holm, Ida E., Monti, Giulia, Kjølby, Mads , Vægter, Christian Bjerggaard , Nyegaard, Mette , Nykjær, Anders , Andersen, Olav M.

Mayo Clinic

Alzheimer's & Dementia | October 22, 2018 | Volume: 14 | Issue: 7S_Part_29 | Pages: No page available

10.1016/j.jalz.2018.07.081 Get It